Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -10,444 | -7,845 | N/A | N/A |
| Depreciation Amortization | 615 | 521 | N/A | N/A |
| Accounts payable and accrued liabilities | 75 | 146 | N/A | N/A |
| Other Working Capital | 212 | -102 | N/A | N/A |
| Other Operating Activity | -58 | -126 | 0 | 0 |
| Operating Cash Flow | $-9,600 | $-7,406 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -233 | -228 | N/A | N/A |
| Investing Cash Flow | $-233 | $-228 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 6,800 | N/A | N/A | N/A |
| Debt Repayment | -612 | -551 | N/A | N/A |
| Common Stock Issued | 5 | N/A | N/A | N/A |
| Other Financing Activity | 4,581 | 0 | 0 | 0 |
| Financing Cash Flow | $10,774 | $-551 | $N/A | $N/A |
| Beginning Cash Position | 1,702 | 9,887 | N/A | N/A |
| End Cash Position | 2,643 | 1,702 | N/A | N/A |
| Net Cash Flow | $941 | $-8,185 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -9,600 | -7,406 | N/A | N/A |
| Capital Expenditure | -233 | -228 | N/A | N/A |
| Free Cash Flow | -9,833 | -7,634 | 0 | 0 |